Pfizer, BioNTech get USFDA approval, authorization for Omicron KP.2 adapted COVID vaccine Ruchika Sharma23 Aug 2024 12:30 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics...
London HC decision fuels continued legal battle between Pfizer, Moderna over COVID vaccine patents Ruchika Sharma4 July 2024 4:10 PM ISTLondon: Pfizer and Moderna's legal dispute over their competing COVID-19 vaccines is poised to persist following a mixed ruling from London's...
COVID vaccine: Moderna wins patent case in Europe against Pfizer, BioNTech Ruchika Sharma19 May 2024 1:00 PM ISTLondon: Moderna announced on Friday that it has emerged victorious in a case at the European Patent Office against Pfizer and BioNTech concerning...
Pfizer slashes full-year revenue forecast by 13 percent on lower COVID sales Ruchika Sharma15 Oct 2023 11:30 AM ISTNew York: Pfizer has slashed its full-year revenue forecast by 13% and said it will cut $3.5 billion worth of jobs and expenses due to...
Pfizer, BioNTech gets USFDA nod for 2023-2024 COVID vaccine Ruchika Sharma12 Sept 2023 12:30 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental...
Pfizer-BioNTech updated COVID vaccine approved by UK regulator Ruchika Sharma6 Sept 2023 10:00 AM ISTBengaluru: The UK drug regulator said on Tuesday it has approved an updated COVID-19 vaccine by Pfizer and its German partner BioNTech that targets...
Pfizer, BioNTech receive positive CHMP opinion for Omicron XBB.1.5-adapted COVID vaccine in EU Ruchika Sharma1 Sept 2023 2:46 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...
Side effects of COVID vaccine: BioNTech faces first German lawsuit Ruchika Sharma12 Jun 2023 10:00 AM ISTThe plaintiff claims she suffered upper-body pain, swollen extremities, fatigue and sleeping disorder due to the vaccine.
Patent infringement: Alnylam Pharma files new lawsuits against Pfizer, Moderna over COVID vaccines Ruchika Sharma27 May 2023 3:18 PM ISTAlnylam is again seeking an unspecified share of royalties from the companies' vaccine sales.
Pfizer beats Q1 profit estimates on demand for newly acquired drugs, COVID products Ruchika Sharma5 May 2023 12:30 PM ISTThe company said it expects significantly lower sales contributions from COVID products in the second quarter from the first quarter.
BioNTech plans to spend about USD 1 billion more on research this year Ruchika Sharma30 March 2023 10:00 AM ISTThe company said it expects to authorise new share buybacks worth up to $500 million this year, having already spent $1.3 billion on own shares...
Pfizer gets USFDA emergency use nod for Omicron BA.4/BA.5-adapted bivalent COVID booster in children under 5 years Ruchika Sharma15 March 2023 12:15 PM ISTThe Pfizer-BioNTech COVID-19 Vaccines (COMIRNATY) are based on BioNTech's proprietary mRNA technology and were developed by both BioNTech and Pfizer.
